Non-cystic Fibrosis Bronchiectasis Clinical Trials

9 recruitingLast updated: May 4, 2026

Non-cystic Fibrosis Bronchiectasis Trials at a Glance

9 actively recruiting trials for non-cystic fibrosis bronchiectasis are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in Chapel Hill, Kansas City, and Belfast. Lead sponsors running non-cystic fibrosis bronchiectasis studies include CSL Behring, Genentech, Inc., and AstraZeneca.

Browse non-cystic fibrosis bronchiectasis trials by phase

About Non-cystic Fibrosis Bronchiectasis Clinical Trials

Looking for clinical trials for Non-cystic Fibrosis Bronchiectasis? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Non-cystic Fibrosis Bronchiectasis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Non-cystic Fibrosis Bronchiectasis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE

Non-cystic Fibrosis Bronchiectasis
AstraZeneca320 enrolled38 locationsNCT07245407
Recruiting
Not Applicable

Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis

Non-cystic Fibrosis Bronchiectasis
Physio-Assist622 enrolled57 locationsNCT06487273
Recruiting
Phase 1Phase 2

A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease

Chronic Obstructive Pulmonary DiseaseNon-cystic Fibrosis Bronchiectasis
Genentech, Inc.128 enrolled7 locationsNCT06603246
Recruiting
Phase 1

A Clinical Study of RSS0343 in Healthy Subjects

Non-cystic Fibrosis Bronchiectasis
Reistone Biopharma Company Limited48 enrolled1 locationNCT07289464
Recruiting
Not Applicable

Breathing Training and Exercise Capacity in Non-CFB

Non-cystic Fibrosis Bronchiectasis
Mayo Clinic50 enrolled1 locationNCT05860803
Recruiting
Phase 2

Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)

Non-cystic Fibrosis Bronchiectasis
CSL Behring450 enrolled13 locationsNCT07048262
Recruiting
Phase 2

A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

Non-cystic Fibrosis Bronchiectasis
Verona Pharma plc180 enrolled50 locationsNCT06559150
Recruiting
Phase 4

Hypertonic Saline in NCFB

BronchiectasisNon-cystic Fibrosis Bronchiectasis
University of North Carolina, Chapel Hill20 enrolled1 locationNCT06242795
Recruiting
Phase 3

A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis

Non-cystic Fibrosis Bronchiectasis
Haisco Pharmaceutical Group Co., Ltd.669 enrolled2 locationsNCT06660992